Spruce Biosciences, Inc. (SPRB)
$44.05-3.27%Close
SELLCRISIS · day 14
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $60M
- Beta
- 3.30
- P/E (TTM)
- -1.05
- Short % float
- 47.48%
- Days to cover
- 4.5
- SI change
- +3.7%
- 1W
- -3.63%
- 1M
- -18.95%
- vs SPY 1W
- -4.79%
- vs SPY 1M
- -21.94%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on SPRB?
- LOPJLB’s latest quantitative signal on Spruce Biosciences, Inc. (SPRB) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is SPRB in?
- Spruce Biosciences, Inc. (SPRB) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Spruce Biosciences, Inc. (SPRB) do?
- Spruce Biosciences, Inc., founded in 2014 and situated in Daly City, California, operates as a biopharmaceutical enterprise. Its primary objective is to advance and bring to market innovative treatments, particularly for uncommon endocrine conditions. A central component of its therapeutic pipeline is tildacerfont, a non-steroidal drug candidate. This compound is currently undergoing Phase 2b c…